Diabetes results from a late change in the autoimmune response of NOD mice

Journal of Autoimmunity

Volumn 10, Issue 3, 1997, Pages 261-270

  Gazda, Lawrence S ^a   Charlton, Brett ^a   Lafferty, Kevin J ^a  

^a Biology and Environment   (Australia)

Author keywords

Autoimmunity; IDDM; T cell; cell

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CONFERENCE PAPER; CONTROLLED STUDY; HYPERGLYCEMIA; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0031170822     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0138     Document Type: Conference Paper

References (47)

1. Bottazzo G.F., Florin-Christensen A., Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 30; 2(7892):1974;1279-1283.
2. Bach J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:1994;516-542.
3. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 14:1965;619-633.
4. Kloppel, G. Heitz, P.U. 1984, Islet histopathology in diabetes mellitus, Pancreatic Pathology, Churchill Livingstone, Edinburgh.
5. Foulis A.K., Liddle C.N., Farquharson M.A., Richmond J.A., Weir R.S. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25 year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia. 29:1986;267-274.
6. Junker K., Egeberg J., Kromann H., Nerup J. An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol. Microbiol. Scand. 85:1977;699-706.
7. Hanafusa T., Miyazaki A., Miyagawa J., Tamura S., Inada M., Yamada K., Shinji Y., Katsura H., Yamagata K., Itoh N., Asakawa H., Nakagawa C., Otsuka A., Kawata S., Kono N., Tarui S. Examination of islets in the pancreas biopsy specimens from newly diagnosed type 1 (insulin-dependent) diabetic patients. Diabetologia. 33:1990;105-111.
8. Gorsuch A.N., Lister J., Dean B.M., Spencer K.M., McNally J.M., Bottazzo G.F. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet Dec 19-26. 2(8260-8261):1981;1363-1365.
9. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 222:1983;1337-1339.
10. Srikanta S., Ganda O.P., Rabizadeh A., Soeldner J.S., Eisenbarth G.S. First-degree relatives of patients with type 1 diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. N. Engl. J. Med. 313:1985;461-464.
11. Atkinson M.A., Maclaren N.K., Riley W.J., Winter W.E., Fisk E.D., Spillar R.P. Are insulin antibodies markers for insulin-dependent diabetes mellitus? Diabetes. 35:1986;894-898.
12. Vardi P., Dib S.A., Tuttleman M., Connelly J.E., Grinbergs M., Radizabeh A., Riley W.J., Maclaren N.K., Eisenbarth G.S., Soeldner J.S. Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes. 36:1987;1286-1291.
13. Bonifacio E., Bingley P.J., Shattock M., Dean B.M., Dunger D., Gale E.A., Bottazzo G.F. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet. 335:1990;147-149.
14. Riley W.J., Maclaren N.K., Krischer J., Spillar R.P., Silverstein J.H., Schatz D.A., Schwartz S., Malone J., Shah S., Vadheim C., Rotter J.I. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N. Engl. J. Med. 323:1990;1167-1172.
15. Eisenbarth G.S. Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314:1986;1360-1368.
16. Kikutani H., Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51:1992;285-322.
17. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. Breeding of a non-obese, diabetic strain of mice. Exp. Anim. 29:1980;1-13.
18. Kanazawa Y., Komeda K., Sato S., Mori S., Akanuma K., Takaku F. Non-obese-diabetic mice: immune mechanisms of pancreatic β-cell destruction. Diabetologia. 27:1984;113-115.
19. Maruyama T., Takei I., Taniyama M., Kataoka K., Matsuki S. Immunological aspect of non-obese diabetic mice: immune islet cell-killing mechanism and cell-mediated immunity. Diabetologia. 27:1984;121-123.
20. Pontesilli O., Carotenuto P., Gazda L.S., Pratt P.F., Prowse S.J. Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol. 70:1987;84-93.
21. Maruyama T., Takei I., Yanagawa T., Takahashi T., Asaba Y., Kataoka K., Ishii T. Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin-induced diabetic mice. Diabetes Res. 7:1988;93-96.
22. Ziegler A.G., Vardi P., Ricker A.T., Hattori M., Soeldner J.S., Eisenbarth G.S. Radioassay determination of insulin autoantibodies in NOD mice. Correlation with increased risk of progression to overt diabetes. Diabetes. 38:1989;358-363.
23. Gazda L.S., Gilchrist K.A., Lafferty K.J. Autoimmune diabetes: caught in the causality trap? Immunol. Cell Biol. 73:1995;549-551.
24. Shehadeh N.N., LaRosa F., Lafferty K.J. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:1993;291-300.
25. Gazda L.S., Baxter A.G., Lafferty K.J. Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies. Immunol. Cell Biol. 74:1996;401-407.
26. Atkinson M.A., Maclaren N.K. Mechanisms of disease - the pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331:1994;1428-1436.
27. Oldstone M.B.A. Viruses as therapeutic agents I. Treatment of nonobese insulin-dependent mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J. Exp. Med. 171:1990;2077-2089.
28. Wilberz S., Partke H.J., Dagnaes-Hansen F., Herberg L. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia. 34:1991;2-5.
29. Takei I., Asaba Y., Kasatani T., Maruyama T., Watanabe K., Yanagawa T., Saruta T., Ishii T. Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. J. Autoimmun. 5:1992;665-673.
30. Hermitte L., Vialettes B., Naquet P., Atlan C., Payan M.J., Vague P. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus. Eur. J. Immunol. 20:1990;1297-1303.
31. Signore A., Procaccini E., Toscano A.M., Ferretti E., Williams A.J.K., Beales P.E., Cugini P., Pozzilli P. Histological study of pancreatic beta-loss in relation to the insulitis process in the non-obese diabetic mouse. Histochemistry. 101:1994;263-269.
32. Wong S., Guerder S., Visintin I., Reich E.-P., Swenson K.E., Flavell R.A., Janeway C.A., Jr. Expression of the co-stimulator molecule B7-1 in pancreatic β-cells accelerates diabetes in the NOD mouse. Diabetes. 44:1995;326-329.
33. Slattery R.M., Kjer-Nielsen L., Allison J., Charlton B., Mandel T.E., Miller J.F.A.P. Prevention of diabetes in non-obese diabetic I-Aκ transgenic mice. Nature. 345:1990;724-726.
34. Nishimoto H., Kikutani H., Yamamura K., Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature. 328:1987;432-434.
35. Bowen K.M., Andrus L., Lafferty K.J. Successful allotransplantation of mouse pancreatic islets to nonimmunosuppressed recipients. Diabetes. 29:1980;98-104.
36. Hicken P., Krohn P.L. The histocompatibility requirements of ovarian grafts in mice. Proc. R. Soc. London. 151:1960;419-433.
37. Rohane P.W., Shimada A., Kim D.T., Edwards C.T., Charlton B., Shultz L.D., Fathman C.G. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Diabetes. 44:1995;550-554.
38. Wang Y., Pontesilli O., Gill R.G., La Rosa F.G., Lafferty K.J. The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA. 88:1991;527-531.
39. Srikanta S., Ganda O.P., Gleason R.E., Jackson R.A., Soeldner J.S., Eisenbarth G.S. Linear loss of beta cell response to intravenous glucose. Diabetes. 33:1984;717-720.
40. Dotta F., Eisenbarth G.S. Type 1 diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of β cell destruction. Clin. Immunol. Immunopathol. 50:1989;585-595.
41. Fujinami R.S., Oldstone M.B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 230:1985;1043-1045.
42. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:1995;695-705.
43. Oldstone M. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science. 239:1988;500-502.
44. Menser M.A., Forrest J.M., Bransby R.D. Rubella infection and diabetes mellitus. Lancet. 1:1978;57-60.
45. Debussche X., Lormeau B., Boitard C., Toublanc M., Assan R. Course of pancreatic beta cell destruction in prediabetic NOD mice: a histomorphometric evaluation. Diabetes Metab. 20:1994;282-290.
46. Itoh A., Maki T. Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis. Proc. Natl. Acad. Sci. USA. 93:1996;11053-11056.
47. Andre I., Gonzalez A., Wang B., Katz J., Benoist C., Mathis D. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA. 93:1996;2260-2263.